Real-World Data (RWD) Hub

Real-world data holds the power to impact patient outcomes. Read our article on RWD benefits and how it impacts the patient journey.

A sponsor struggled to recruit non-small cell lung cancer patients with a specific genetic mutation and who also met a list of exclusion criteria and sought guidance on which HCPs to contact for patient referrals, as well as help with outreach.

Before finalizing its clinical trial protocol, a sponsor wanted to analyze three iterations of eligibility criteria, with several goals in mind: Ensure they weren’t looking for a “needle in a haystack,” confirm the ability to enroll diverse patient populations, and avoid unnecessary exclusion of patients.

To combat the costly challenges of patient recruitment, sponsors can leverage real-world data. RWD can target eligible patients, locate investigators, and pinpoint clinical trial sites for clinical success.

To tackle rare disease recruitment challenges, sponsors are coupling tech-enabled, patient-centric approaches with real-world evidence & real-world data.

Take a patient-centric view of your clinical trial planning and execution and unlock real-world insights for transformative clinical outcomes.

Citeline RWD assets include medical claims and lab test/results data (including biomarkers and genomics), global electronic health records (EHRs), census and CMS data, and more.

This use case illustrates how Citeline’s robust datasets, combined with real-world data, inform intelligent clinical trial site and investigator selection.

Download our flyer to learn how our Consulting & Analytics team generates accurate, actionable insights on patients, sites, investigators, and more — that you can’t get from AI alone.